Eileen Gülke

Dr. Eileen Gülke

University Medical Center Hamburg-Eppendorf
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
EGEileen Gülke
Eileen Gülke
MPMonika Pötter-Nerger
Monika Pötter-Nerger
In Parkinson’s disease (PD) patients, the progressive nature of the disease and the variability of disabling motor and non-motor symptoms contribute to the growing caregiver burden of PD partners and conflicts in their relationships. Deep brain stimulation (DBS) improves PD symptoms and patients’ quality of life but necessitates an intensified therapy optimization after DBS surgery. This review illuminates caregiver burden in the context of DBS, framing both pre- and postoperative aspects. We aim to provide an overview of perioperative factors influencing caregiver burden and wish to stimulate further recognition of caregiver burden of PD patients with DBS.

7 April 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EGEileen Gülke
Eileen Gülke
MAMohammad Alsalem
Mohammad Alsalem
MKMaja Kirsten
Maja Kirsten
EVEik Vettorazzi
Eik Vettorazzi
CCChi-Un Choe
Chi-Un Choe
MPMonika Pötter-Nerger
Monika Pötter-Nerger
Introduction: The preoperative evaluation of Parkinson’s Disease (PD) patients for subthalamic nucleus deep brain stimulation (STN-DBS) includes the assessment of the neuropsychological status of the patient. A widely used preoperative test is the Mattis Dementia rating scale (MDRS). However, the Montreal cognitive assessment (MoCA) has also been proven to be a sensitive, time-sparing tool with high diagnostic validity in PD. We evaluate the utility of the MoCA as a preoperative screening test for PD patients undergoing bilateral STN-DBS.Methods: In this single-centre, retrospective study, we analysed pre- and postoperative assessments of MoCA, MDRS, Movement disorder society-Unified PD Rating Scale-motor examination, PD Questionnaire-39 and levodopa equivalent daily dose. Longitudinal outcome changes were analysed using paired t-test, Pearson’s correlation coefficient, linear regression and CHAID (chi-square automatic interaction detector) regression tree model.Results: Clinical motor and cognitive scores of 59 patients (61.05±7.73 years, 24 females) were analysed. The MoCA, but not the MDRS, identified significant postoperative cognitive decline in PD patients undergoing STN-DBS. The preoperative MoCA score correlated with postoperative quality of life improvement, whereas the MDRS did not. PD patients with a MoCA score ≤ 23 points had a significant decline of quality of life after DBS surgery compared to patients > 23 points.Conclusion: This study identifies the MoCA as an alternative test within the preoperative evaluation of PD patients for the detection of neuropsychological deficits and prediction of the postoperative improvement of quality of life.

29 October 2022 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
EGEileen Gülke
Eileen Gülke
LPLeón Juárez Paz
León Juárez Paz
HSHeleen Scholtes
Heleen Scholtes
CGChristian Gerloff
Christian Gerloff
AKAndrea A. Kühn
Andrea A. Kühn
MPMonika Pötter-Nerger
Monika Pötter-Nerger
Technological advances of Deep Brain Stimulation (DBS) within the subthalamic nucleus (STN) for Parkinson’s disease (PD) provide increased programming options with higher programming burden. Reducing the effort of DBS optimization requires novel programming strategies. The objective of this study was to evaluate the feasibility of a semi-automatic algorithm-guided-programming (AgP) approach to obtain beneficial stimulation settings for PD patients with directional DBS systems. The AgP evaluates iteratively the weighted combination of sensor and clinician assessed responses of multiple PD symptoms to suggested DBS settings until it converges to a final solution. Acute clinical effectiveness of AgP DBS settings and DBS settings that were found following a standard of care (SoC) procedure were compared in a randomized, crossover and double-blind fashion in 10 PD subjects from a single center. Compared to therapy absence, AgP and SoC DBS settings significantly improved (p = 0.002) total Unified Parkinson’s Disease Rating Scale III scores (median 69.8 interquartile range (IQR) 64.6|71.9% and 66.2 IQR 58.1|68.2%, respectively). Despite their similar clinical results, AgP and SoC DBS settings differed substantially. Per subject, AgP tested 37.0 IQR 34.0|37 settings before convergence, resulting in 1.7 IQR 1.6|2.0 h, which is comparable to previous reports. Although AgP long-term clinical results still need to be investigated, this approach constitutes an alternative for DBS programming and represents an important step for future closed-loop DBS optimization systems.

21 March 2026 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
EGEileen Gülke
Eileen Gülke
SLSimon J G Lewis
Simon J G Lewis
Freezing of Gait (FOG) research is entering a rapidly evolving phase. Published in early 2026, the International Consortium for FOG (ICFOG) released updated clinical and technical definitions of FOG and introduced a consensus-based standardized testing protocol, the Giladi protocol (GP-FOG), which is currently still under evaluation in an ongoing study. Complementing these advances, two new outcome measures, the clinician-reported outcome (ClinRO) and the patient-reported outcome (PRO), are highlighted in this review. Recent technological developments in both detection and potential prevention of FOG are moving the field toward individualized, biomarker-based, on-demand treatment strategies. In addition, emerging insights into the pathophysiological mechanisms of FOG, particularly nondopaminergic contributions, are discussed. Together, these developments provide a contemporary framework for improving the assessment, understanding, and personalized management of FOG in Parkinson’s disease.

15 June 2025 in Practical Neurology
Verified
Journal Article
Closed access
PDF file
EGEileen Gülke
Eileen Gülke
SLSimon J G Lewis
Simon J G Lewis

6 December 2021 in Fortschritte der Neurologie · Psychiatrie
Verified
Journal Article
Closed access
PDF file
EGEileen Gülke
Eileen Gülke
CGChristian Gerloff
Christian Gerloff
Seit ersten Berichten einer neuen Atemwegsinfektion aus der Hauptstadt Wuhan der zentralchinesischen Provinz Hubei Ende 2019 breitet sich das Coronavirus SARS-CoV-2 weltweit aus. Mittlerweile ist bekannt, dass eine COVID-19-Infektion häufig begleitet wird von neurologischen Symptomen und Komplikationen. Dieser Artikel beleuchtet die klinische Relevanz der COVID-19-Pandemie für die Neurologie im Allgemeinen und insbesondere im Hinblick auf an Parkinson vorerkrankte Patienten. After first reports of a new predominantely respiratory illness detected in Wuhan City, Hubei Province of China in Dezember 2019, the novel coronavirus SARS-CoV-2 rapidly spreads all over China and the world. Growing evidence suggests that neurological signs, symptoms and complications occur during the course of the COVID-19 disease. This article highlights neurological aspects of COVID-19 and also discusses the impact of the COVID-19 pandemic on patients with Parkinson’s disease. Publication Date: 06 December 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG, Rüdigerstraße 14, 70469 Stuttgart, Germany